Atezolizumab Associated Rapidly Progressive PauciImmune Glomerulonephritis- A Case Report

Laura Gosztonyi
Additional contact information
Laura Gosztonyi: Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Switzerland

Biomedical Journal of Scientific & Technical Research, 2023, vol. 53, issue 5, 45150-45153

Abstract: Immune Checkpoint Inhibitors (ICI) are increasingly prescribed as therapy for a broad spectrum of cancers and have over the past decade contributed to revolutionizing the oncology field. While these humanized monoclonal antibodies have significantly improved survival rates, they are also associated with a variety of autoimmune adverse events.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008464.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008464.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:53:y:2023:i:5:p:45150-45153

DOI: 10.26717/BJSTR.2023.53.008464

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().